Bliss Cunningham

Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection

Yogitha N Srikhanta, Melanie L Hutton, Milena M Awad, Nyssa Drinkwater, Julie Singleton, Sophie L Day, Bliss A Cunningham, Sheena McGowan, Dena Lyras

Journal article  |  2019  |  Nature Microbiology

Spore-forming bacteria encompass a diverse range of genera and species, including important human and animal pathogens, and food c..

Dietary zinc and the control of Streptococcus pneumoniae infection

Bart A Eijkelkamp, Jacqueline R Morey, Stephanie L Neville, Aimee Tan, Victoria G Pederick, Nerida Cole, Prashina P Singh, Cheryl-Lynn Y Ong, Raquel Gonzalez de Vega, David Clases, Bliss A Cunningham, Catherine E Hughes, Iain Comerford, Erin B Brazel, Jonathan J Whittall, Charles D Plumptre, Shaun R McColl, James C Paton, Alastair G McEwan, Philip A Doble, et al.

Journal article  |  2019  |  PLOS Pathogens

Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative

Melanie L Hutton, Bliss A Cunningham, Kate E Mackin, Shelley A Lyon, Meagan L James, Julian I Rood, Dena Lyras

Journal article  |  2017  |  Scientific Reports

Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections

Glen P Carter, Anjana Chakravorty, Anh Pham Nguyen Tu, Steven Mileto, Fernanda Schreiber, Lucy Li, Pauline Howarth, Simon Clare, Bliss Cunningham, Susan P Sambol, Adam Cheknis, Iris Figueroa, Stuart Johnson, Dale Gerding, Julian I Rood, Gordon Dougan, Trevor D Lawley, Dena Lyras

Journal article  |  2015  |  mBio